IPSEN (OTCMKTS:IPSEY) Shares Gap Down – Here’s What Happened

IPSEN (OTCMKTS:IPSEY)’s share price gapped down prior to trading on Monday. The stock had previously closed at $41.8975, but opened at $39.40. IPSEN shares last traded at $39.75, with a volume of 9,640 shares changing hands.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on IPSEY shares. Jefferies Financial Group lowered shares of IPSEN from a “hold” rating to a “moderate sell” rating in a research note on Sunday, August 2nd. HC Wainwright reiterated a “buy” rating on shares of IPSEN in a report on Tuesday, June 30th. Finally, Barclays raised IPSEN from a “strong sell” rating to a “hold” rating in a research report on Thursday, September 17th. Two equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, IPSEN has an average rating of “Hold”.

IPSEN Stock Performance

The stock has a 50-day simple moving average of $45.72 and a 200-day simple moving average of $46.44.

IPSEN Company Profile

Ipsen SA is a France-based biopharmaceutical company focused on the discovery, development and commercialization of medicines in specialty care. Its principal therapeutic areas are oncology, rare diseases and neuroscience, with an emphasis on treatments for conditions that often have limited therapeutic options.

The company’s portfolio includes Somatuline (lanreotide) for certain neuroendocrine tumors and endocrine disorders, Dysport (abobotulinumtoxinA) for selected movement disorders and aesthetic applications, and cancer treatments such as Cabometyx and Onivyde.